As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
InveniAI applies machine learning across scientific literature, patents, trials and funding data to spot emerging biomedical opportunities. Founded in 2010 in Connecticut, its Alpha platform supports asset search, indication expansion and competitive intelligence for pharmaceutical clients. The company also develops its own repurposed drug pipeline.
News
InveniAI Announces Launch of AlphaMeld Corporation and Major Milestone Updates to Reflect Cutting-Edge Innovation in AI-Driven Drug Discovery
Read more
Report
Ono Pharma inks research agreement with InveniAI to identify novel therapeutics
Ono Pharma inks research agreement with InveniAI to identify novel therapeutics
Read more
Report
InveniAI's AlphaMeld Platform Debuts the Addition of ChatAlphaMeld, A Powerful Tool Designed to Scale Target and Drug Discovery and Development
Read more
Report
Kyowa Kirin expands Inveniai AI platform collaboration once again
Inveniai LLC and Kyowa Kirin Co. Ltd. have expanded their partnership a second time, inking their most recent multiple drug discovery agreement. The multiyear deal will see the duo discover novel targets and treatments for therapeutic areas across Kyowa K
Read more
Report
InveniAI and Kyowa Kirin Expand AI-Driven Partnership to a Multi-Year Strategic Collaboration for the Discovery of Novel Targets and Treatments Across Therapeutic Areas
--InveniAI LLC, a global leader in applying Artificial Intelligence and Machine Learning to transform drug discovery and development, and Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company creating innovative medical solutions utilizing the
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
